Daily Archives: 28 January, 2025

October 2024 | Oncimmune announces a the raise of a minimum of £2.0 million equity and an amendment to the facility agreement with IPF Partners, including a partial conversion of debt to equity

Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe-based and needle-based confocal laser endomicroscopy (pCLE/ nCLE ) platform…

October 2024 – Kneat announces closing of $35.6 million bought deal

Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe-based and needle-based confocal laser endomicroscopy (pCLE/ nCLE ) platform…

September 2024 | Poxel Announces an agreement with OrbiMed to monetize a portion of TWYMEEG® royalties for US$50 million and the restructuring of the IPF Partners debt facility

Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe-based and needle-based confocal laser endomicroscopy (pCLE/ nCLE ) platform…

August 2024 – Health Catalyst Acquires Lumeon

Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe-based and needle-based confocal laser endomicroscopy (pCLE/ nCLE ) platform…

August 2024 – Caresyntax raises $180 million funding to accelerate growth and adoption of precision surgery

Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe-based and needle-based confocal laser endomicroscopy (pCLE/ nCLE ) platform…

June 2024 | Faron publishes the final result of the fully subscribed €30.7 million share offering

Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe-based and needle-based confocal laser endomicroscopy (pCLE/ nCLE ) platform…

May 2024 | IPF Partners Closes a Debt Financing with Avi Medical to Fund Clinic Network Expansion

Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe-based and needle-based confocal laser endomicroscopy (pCLE/ nCLE ) platform…